• leader board size

News

Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations

BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark a cautious expansion of therapies using psilocybin, with Switzerland also permitting limited use of LSD and MDMA, signaling a shift ...

November 21st, 2025|Psychedelics|

Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase

SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings Ltd. and extend its operational cash flow for more than a year. The deal, announced this week, involves U.S.-based lenders ...

November 20th, 2025|Business, International|

West Virginia Medical Cannabis Costs Drive Patients Across State Lines for Lower-Priced Options

CHARLESTON – Elevated prices in West Virginia's medical Cannabis system continue to steer registered patients toward recreational outlets in Ohio, Maryland, and Michigan, where products sell at fractions of the cost despite legal barriers to transport. The state's program, active since 2017 with dispensaries opening in 2021, now counts 35,000 cardholders, but registrations have stalled ...

November 20th, 2025|Markets|

Florida Takes Action to Advance Adult-Use Cannabis Ballot Measure, Lawsuit Ends Delay

TALLAHASSEE – Florida election officials cleared a procedural roadblock for a proposed constitutional amendment to legalize recreational Cannabis, submitting the measure to the state attorney general's office just weeks after advocates sued over perceived delays in the review process. The move sets the stage for scrutiny by the Florida Supreme Court on the ballot language's ...

November 19th, 2025|Local Politics|

Viridian Capital Advisors Reports Valuation Metrics for U.S. MSOs with Market Caps >$100M

LOS ANGELES – Multi-state cannabis operators in the United States are carrying valuation multiples that signal caution among investors, even as growth prospects brighten for the coming year. According to a fresh Weekly Valuation Report from Viridian Capital Advisors, the 11 publicly traded MSOs with market capitalizations exceeding $100 million posted a median enterprise value ...

November 18th, 2025|Insights|

OPINION: Industrial hemp just got ‘future proofed.’

NEW YORK- Industrial hemp just received the clearest signal yet that it's not a fad, not a loophole, and not going away. It was effectively declared “future proof.” When Congress passed the funding bill to reopen the federal government last week, it did more than end a shutdown. It rewrote the rules for the entire ...

November 17th, 2025|Business, Insights|

New York Updates Cannabis Packaging, Labeling, and Advertising Regulations

NEW YORK – The New York State Cannabis Control Board finalized amendments to its packaging, labeling, marketing, and advertising regulations, marking a significant step in refining the state's adult-use Cannabis market. The changes aim to enhance consumer safety, curb youth appeal, and promote environmental responsibility, while offering operators clearer guidelines for compliance. The adoption follows ...

November 14th, 2025|Compliance|

Planet 13 Reports Q3 2025 Financial Results

LAS VEGAS – Planet 13 Holdings Inc., a multistate Cannabis operator with flagship operations in Nevada and Florida, disclosed a $44 million net loss for the third quarter, reflecting the toll of compressed prices, softening demand, and one-time charges across its portfolio. Revenue fell to $23.3 million, a 27.6% drop from $32.2 million a year ...

November 14th, 2025|Report|

Glass House Brands Reports Q3 2025 Financial Results

LONG BEACH – Glass House Brands Inc. disclosed third-quarter 2025 earnings that showed a marked slowdown in sales and profitability, chalked up to deliberate shifts in its labor strategy. The company posted revenue of $38.4 million for the period, meeting the high end of its forecast but marking a steep 40% decline from $63.8 million ...

November 14th, 2025|Report|

ANTG Inks Deal with Curaleaf to Supply Medical Cannabis for UK Patients

LONDON – Australian Natural Therapeutics Group, a leading cultivator of pharmaceutical-grade Cannabis, has reached an agreement with Curaleaf Laboratories to bring its products to British patients, marking a cross-continental push into Europe's second-largest medical Cannabis market. Under the terms, ANTG will export its Australian-grown formulations to Curaleaf's EU-GMP certified facility in the United Kingdom, where ...

November 13th, 2025|International|

Trump Signs Funding Measure Ending Historic 43-Day Government Shutdown, Bans Hemp-Derived THC Products

WASHINGTON – President Donald Trump signed a bipartisan spending package that reopens the federal government after a 43-day impasse, marking the longest such closure in American history. Tucked into the legislation, however, are new limits on hemp-derived products that effectively prohibit most intoxicating varieties, reshaping a sector that has grown into a $28 billion market ...

November 13th, 2025|US Politics|

OPINION: Careful What You Wish For, You Might End Up With A 12-Inch Pianist 

LOS ANGELES- The regulated cannabis industry should be collectively objecting to the language in the Big Beautiful Bill that effectively makes intoxicating hemp products illegal in 12 months.  They should be screaming from the roof like Tevye!  For those in the regulated cannabis industry celebrating  Congress' budget language that will effectively stall the intoxicating hemp ...

November 12th, 2025|Business, Insights|

Flower by Edie Parker Teams Up with Verano for Florida Cannabis Debut, Spotlights Rapper JT in Promo Campaign

MIAMI – Flower by Edie Parker, a female-founded, premium Cannabis brand known for its vibrant designs, has struck an exclusive deal with Verano Holdings Corp. to roll out its products across the Sunshine State's medical Cannabis dispensaries, marking a calculated push into one of the nation's largest patient markets. The agreement brings Flower by Edie ...

November 12th, 2025|Business|

AbbVie Reveals $900M Upfront Payment in Psychedelic Deal, Signaling Strong Bet on Bretisilocin

CHICAGO – AbbVie Inc. disclosed in a recent securities filing that it handed over $900 million in cash at the outset of its acquisition of bretisilocin, the experimental psychedelic compound acquired from Gilgamesh Pharmaceuticals aimed at treating major depressive disorder (MDD). The revelation, uncovered in the company's Q3 2025 report, fills in a key blank ...

November 12th, 2025|Psychedelics|

Rubicon Organics Secures $4M Financing for Facility Upgrades

VANCOUVER, BC – Rubicon Organics Inc. closed a $4 million credit package with Community Savings Credit Union to finance upgrades at its production sites. The deal breaks down into a $3 million term loan carrying a five-year maturity and a 10-year repayment schedule at 6.79% interest, plus a $1 million revolving line priced at the ...

November 12th, 2025|Capital|

The Intoxicating Hemp Ban Is About to Become Law — and It’s a Pyrrhic Victory for Cannabis

LOS ANGELES- The federal government just erased a $20-billion industry under the guise of “closing a loophole.” But rather than protecting consumers, Washington has dealt a crippling blow to both hemp and legal Cannabis — leaving no winners, only fallout. The U.S. Senate has passed legislation redefining hemp to include all forms of THC — ...

November 11th, 2025|Business, Insights|

Senate Spending Package Eyes Hemp THC Crackdown as Shutdown Continues, Trump Backs Restrictions

WASHINGTON – A bipartisan spending package drafted to end the nation's longest government shutdown now includes a provision that would sharply curtail sales of hemp-derived THC products, garnering White House endorsement and fierce opposition from industry advocates. The measure, advanced and failed by the Senate on a 76-24 vote Monday, sets a federal cap of ...

November 11th, 2025|US Politics|

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – Operators sharpened their focus on balance sheets and strategic footholds while policymakers grappled with regulatory gaps and emerging threats. Funding flowed into psychedelics innovation, MSOs reported Q3 2025 earnings, trimmed underperformers, and legacy industries mounted defenses against hemp's rise. These moves reveal sectors doubling down on execution amid uneven growth, where capital ...

November 10th, 2025|The Week in Review|

Cronos Group Reports Q3 2025 Financial Results

TORONTO – Cronos Group Inc., a Canadian Cannabis producer with a growing international footprint, reported third-quarter results that marked new highs for revenue, profitability, and cash reserves, even as domestic challenges in Canada tempered some gains. The company posted net revenue of $36.3 million for the period, up 6% from the prior year and 9% ...

November 7th, 2025|Report|

Aurora Cannabis Reports Q2 FY2026 Financial Results

EDMONTON – Aurora Cannabis Inc. posted a solid second quarter for its fiscal 2026, with total net revenue climbing 11% to CA$90.4 million, driven by a surge in international medical Cannabis sales that highlighted the company's shift away from lower-margin consumer markets. The results, covering the three months ended September 30, 2025, showed global medical ...

November 7th, 2025|Report|

Cresco Labs Reports Q3 2025 Financial Results

CHICAGO – Cresco Labs, a major player in branded Cannabis products and the Sunnyside retail chain, announced third-quarter results showing revenue of $165 million for the period ended September 30. The figure marked a modest sequential increase from the prior quarter, even as the company absorbed costs from a recent debt overhaul. Operating cash flow ...

November 7th, 2025|Report|
Go to Top